Search Job Title Only
News By Subject
News by Disease
News By Date
Get Our FREE
) To Keep 100 Workers After Review
7/11/2014 7:13:19 AM
Pfizer has confirmed that a change in work practices and an upsurge in workload means it is not going to press ahead with 100 of the 130 redundancies it had flagged one of its Cork plants two years ago.
In 2012, it emerged that the company was planning 130 job losses at its Ringaskiddy facility after one of its biggest-selling drugs, the cholesterol-reducing Lipitor, had come off patent. However, a spokeswoman yesterday confirmed Pfizer had decided not to proceed with 100 of the redundancies.
Help employers find you! Check out all the
post your resume
(PFE) Fights Off Shareholder Lawsuit
(NVS) Layoffs Announced: More Cuts May Be Looming
Johnson & Johnson
(JNJ) Give Each Other Headaches Over An Advil Ad
(AZN) To Unveil Cambridge Plans This Week
(PFE) Should Buy
Small But Tenacious: Two Of San Diego's Emerging Biotechs
Sophiris Bio Inc.
To Fend Off
(AZN) Contemplating Sale Of Some Future Revenue From Existing Drugs
Teva Pharmaceutical Industries Limited
(TEVA) Denies Shareholder Claim That A Chairman Has Been Selected
(PFE) Adopts Different Style For New Research Center
(NVS) To Build $35 Million Data Center At
Alcon Laboratories, Inc.
comments powered by Disqus.
comments powered by
Biotech/Pharma - Industry
Biotech/Pharma - Industry, Jobs
Biotech/Pharma - Industry (World)
Biotech/Pharma - Industry, Jobs (World)